News & Updates
Filter by Specialty:

Novel antireflux device shows potential for treatment of PPI-refractory GERD
Patients suffering from gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM) may benefit from the novel RefluxStop device implantation, a safe and minimally invasive technology that offers potential benefits, a study has shown.
Novel antireflux device shows potential for treatment of PPI-refractory GERD
11 Jul 2024
Statin use tied to joint replacement risk
A French study presented at EULAR 2024 reveals an association between statin treatment and an increased risk of total joint replacement in individuals with knee and hip osteoarthritis (OA).
Statin use tied to joint replacement risk
11 Jul 2024
Kidney, heart benefits FLOW with semaglutide
Semaglutide reduces the risk of major kidney disease-related events and death from cardiovascular causes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as shown in the FLOW* study presented at ERA 2024.
Kidney, heart benefits FLOW with semaglutide
10 Jul 2024
TMI, fludarabine, melphalan pass phase I trial as conditioning therapy in multiple myeloma
Fludarabine, melphalan, and total marrow irradiation (TMI) 900 cGy may be utilized as conditioning for allogeneic stem cell transplantation in patients with high-risk or relapsed/refractory multiple myeloma, as shown in a phase I trial.
TMI, fludarabine, melphalan pass phase I trial as conditioning therapy in multiple myeloma
10 Jul 2024
Nomogram predicts acute radiation enteritis in cervical cancer
A nomogram model displays a decent performance in predicting grade ≥2 acute radiation enteritis (ARE) among patients with cervical cancer receiving concurrent chemoradiotherapy, a study has shown.
Nomogram predicts acute radiation enteritis in cervical cancer
10 Jul 2024
Bulky tumours in PCNSL tied to high local treatment failure
Systemic and intrathecal therapies are necessary for local control in patients with primary central nervous system lymphoma (PCNSL), but bulky tumours remain a problem, according to a study.